PubMed:30843003 / 988-1337 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/30843003","sourcedb":"PubMed","sourceid":"30843003","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/30843003","text":"A classification report, which is currently in use, divides patients into three categories according to the risk of having BM: low risk (PSA\u003c10ng/mL, clinical stage T1-T2a, Gleason Score ≤6), intermediate risk (PSA 10.1-20ng/mL, clinical stage T2b-T2c, Gleason Score=7) and high risk (PSA\u003e20ng/mL, clinical stage T3a or higher, or Gleason Score ≥8).","tracks":[{"project":"Inflammaging","denotations":[{"id":"T9","span":{"begin":0,"end":349},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":349},"obj":"Sentence"}],"attributes":[{"subj":"T9","pred":"source","obj":"Inflammaging"},{"subj":"T9","pred":"source","obj":"Inflammaging"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"Inflammaging","color":"#ece093","default":true}]}]}}